Core Nursing Explanation
Key Concept Analysis: This question assesses the nurse's ability to recognize and prioritize a critical, potentially irreversible adverse effect of a first-line anti-tuberculosis medication. The core theme is
drug toxicity management and patient safety. The patient is on a multi-drug regimen for
Pulmonary Tuberculosis (TB). The symptom of new-onset visual disturbance, specifically
red-green color blindness, is a classic and serious sign of
optic neuritis caused by
Ethambutol. Ethambutol toxicity is dose and duration-dependent and can lead to permanent vision loss if the drug is not stopped promptly.
Answer Rationale:
Key Point! The priority nursing intervention is to
discontinue the offending agent immediately and notify the prescriber. This action aligns with the nursing responsibility to protect the patient from harm. Ethambutol-induced optic neuritis is a medical emergency in the context of pharmacotherapy. The nurse, using clinical judgment and knowledge of drug side effects, must act to prevent permanent damage. While notifying the physician is part of the action, the immediate cessation of the drug is the critical first step the nurse can and should take, especially if the physician is not immediately available.
Distractor Analysis:
- Option ② (Reduce lighting/provide sunglasses): This is a supportive measure for photophobia, which is not the primary issue here. The problem is neurotoxic damage to the optic nerve, not light sensitivity. This intervention does not address the root cause and delays definitive action.
- Option ③ (Schedule ophthalmology consult for next week): While an ophthalmology evaluation is absolutely necessary, scheduling it for "next week" introduces an unsafe delay. The priority is to stop the causative drug now to halt further damage, then arrange for urgent evaluation.
- Option ④ (Document and continue monitoring): Documentation is essential, but "continue monitoring" is a passive and dangerous response to a sign of serious toxicity. Monitoring alone allows the drug to continue causing potential irreversible harm.
Related Concepts: This scenario integrates knowledge of infectious disease nursing, pharmacology, and neurological assessment. Understanding the
RIPE regimen (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) for TB is key. Nurses must know the major side effects of each: hepatotoxicity for INH/PZA, orange bodily fluids for Rifampin, and optic neuritis/hyperuricemia for Ethambutol. Patient education should always include reporting any visual changes when on Ethambutol.
Concept Summary
| Concept | Key Points |
| Ethambutol Toxicity | Causes optic neuritis. Symptoms: blurred vision, red-green color blindness, decreased visual acuity. Risk is dose/duration dependent. Can be irreversible. |
| Nursing Priority in Drug Toxicity | 1. STOP the drug. 2. NOTIFY the provider. 3. MONITOR the patient. 4. DOCUMENT thoroughly. |
| Pulmonary TB Treatment | Initial phase: 2-month RIPE regimen. Continuation phase: 4-month INH + Rifampin. Directly Observed Therapy (DOT) is standard. |
| Optic Neuritis | Inflammation of the optic nerve. Ethambutol is a common cause. Other causes include multiple sclerosis, infections. |
Side-by-Side Comparison!
| Adverse Effect | Associated TB Drug | Key Nursing Assessment/Intervention |
| Optic Neuritis (color blindness, vision loss) | Ethambutol | Baseline & monthly vision/color testing. Stop drug immediately if symptoms occur. |
| Hepatotoxicity (jaundice, fatigue, nausea) | Isoniazid (INH), Pyrazinamide (PZA), Rifampin | Monitor LFTs (Liver Function Tests). Educate on avoiding alcohol. Report symptoms. |
| Peripheral Neuropathy (numbness, tingling) | Isoniazid (INH) | Prevent with Pyridoxine (Vitamin B6) supplementation. |
| Hyperuricemia (gout-like joint pain) | Pyrazinamide (PZA) | Monitor for joint pain. Encourage hydration. |
| Orange/Rust-colored bodily fluids | Rifampin | Educate patient that urine, sweat, tears may turn orange. Can stain contact lenses. |
Anatomy, Physiology & Pharmacology Points
- Pharmacology: Ethambutol is bacteriostatic. Its mechanism of action is inhibition of arabinosyl transferase, disrupting mycobacterial cell wall synthesis. Toxicity is related to chelation of copper and zinc, affecting mitochondrial function in the optic nerve.
- Anatomy: The optic nerve (Cranial Nerve II) transmits visual signals from the retina to the brain. The papillomacular bundle, responsible for central vision and color perception, is particularly vulnerable to ethambutol toxicity.
- Physiology: Red-green color vision is mediated by cone cells in the macula. Damage to the neural pathways from these cones manifests as dyschromatopsia (impaired color vision), an early sign of optic nerve inflammation.
Memory Tips
- Mnemonic for Ethambutol side effect: "Eye problems with Ethambutol." Think "E for Eyesight."
- Mnemonic for RIPE regimen side effects: "Rusty fluids, Injure liver & nerves, Painful joints & liver, Eyesight gone."
- Action Priority: Remember the sequence: Stop, Notify, Monitor, Document (SNMD).
High-Frequency NCLEX Topics
This integrates several high-yield NCLEX areas:
Medication Administration & Safety (recognizing adverse effects),
Priority Setting (immediate vs. delayed actions), and
Infectious Disease (TB management). NCLEX loves to test on the specific, classic side effects of first-line TB drugs and the nurse's independent, immediate action required for toxicity.
Watch Out for Question Variations!
- Symptom Identification: "A patient on ethambutol reports 'trouble seeing the color of traffic lights.' What should the nurse suspect?" (Answer: Optic neuritis).
- Patient Education: "What instruction is most important to give a patient starting ethambutol?" (Answer: Report any changes in vision or color perception immediately).
- Priority Intervention (Different Context): If the question was about INH and peripheral neuropathy, the priority might be to administer Pyridoxine as ordered, not necessarily stop the drug, as neuropathy is often manageable/reversible.